THOMA BRAVO, L.P.THOMA BRAVO, L.P.

Institutional investor · Portfolio as of Q4 2022

SEC EDGAR SourceSEC Filings

Top Holdings5 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

DYNATRACE INC

84.3M$3.2B42.3%$18.95+102.11%
14 qtrssince 2019-Q3
Unchanged
0
INSTINSTDelisted

INSTRUCTURE HLDGS INC

122.1M$2.9B37.5%
6 qtrssince 2021-Q3
Unchanged
0
MLNKMLNKDelisted

MERIDIANLINK INC

40.5M$555.6M7.3%
6 qtrssince 2021-Q3
Unchanged
0

N-ABLE INC

50.1M$514.9M6.7%$12.44-17.36%
6 qtrssince 2021-Q3
Unchanged
0
SWISWIDelisted

SOLARWINDS CORP

50.1M$468.8M6.1%
$7.6B
AUM
5
Positions
Q4 2022
Filing
Rating · 1.5
Quarterly Portfolio Change
Not enough history yet
Activity profile
$ moved · Q4'22
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.9 years
<1Q0%1-4Q0%1-2Y60%2Y+40%

THOMA BRAVO, L.P. manages $7.6B across 5 positions as of Q4 2022. Top holdings: DT (42.3%), INST (37.5%), MLNK (7.3%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 1.5/5.0.

Q4 2022 Summary

Held steady with 5 unchanged positions. No standout high-conviction moves this quarter. Portfolio: $7.6B across 5 positions.

Top holdings by portfolio weight

Total AUM$8B
DT42.32%
INST37.50%
MLNK7.28%
NABL6.75%
SWI6.15%

Portfolio allocation by GICS sector

Sectors2
Unknown50.93%
Technology49.07%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Unknown, Technology
Compare DNA across all funds
7-dimension quality assessment
Below Average(1.5 / 5.0)
Track RecordNo data
Conviction39
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used